WEST PHARMACEUTICAL SERVICES INC Quarterly Goodwill in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
West Pharmaceutical Services Inc quarterly Goodwill history and growth rate from Q2 2010 to Q3 2024.
  • West Pharmaceutical Services Inc Goodwill for the quarter ending September 30, 2024 was $109M, a 1.87% increase year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $109M +$2M +1.87% Sep 30, 2024 10-Q 2024-10-24
Q2 2024 $107M -$700K -0.65% Jun 30, 2024 10-Q 2024-07-25
Q1 2024 $108M -$200K -0.19% Mar 31, 2024 10-Q 2024-04-25
Q4 2023 $109M +$1.2M +1.12% Dec 31, 2023 10-Q 2024-10-24
Q3 2023 $107M +$2.8M +2.69% Sep 30, 2023 10-Q 2023-10-26
Q2 2023 $108M +$1.4M +1.31% Jun 30, 2023 10-Q 2023-07-27
Q1 2023 $108M -$1M -0.92% Mar 31, 2023 10-Q 2023-04-27
Q4 2022 $107M -$2.6M -2.37% Dec 31, 2022 10-K 2024-02-20
Q3 2022 $104M -$4.9M -4.5% Sep 30, 2022 10-Q 2022-10-27
Q2 2022 $107M -$3.4M -3.09% Jun 30, 2022 10-Q 2022-07-28
Q1 2022 $109M -$700K -0.64% Mar 31, 2022 10-Q 2022-04-28
Q4 2021 $110M -$1.2M -1.08% Dec 31, 2021 10-K 2024-02-20
Q3 2021 $109M -$400K -0.37% Sep 30, 2021 10-Q 2021-10-28
Q2 2021 $110M +$2.4M +2.23% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $110M +$2.6M +2.43% Mar 31, 2021 10-Q 2021-04-30
Q4 2020 $111M +$3.3M +3.06% Dec 31, 2020 10-K 2023-02-21
Q3 2020 $109M +$2.7M +2.53% Sep 30, 2020 10-Q 2020-10-23
Q2 2020 $108M -$600K -0.56% Jun 30, 2020 10-Q 2020-07-24
Q1 2020 $107M +$1.7M +1.62% Mar 31, 2020 10-Q 2020-04-24
Q4 2019 $108M +$2M +1.89% Dec 31, 2019 10-K 2022-02-22
Q3 2019 $107M +$300K +0.28% Sep 30, 2019 10-Q 2019-10-29
Q2 2019 $108M +$1.6M +1.5% Jun 30, 2019 10-Q 2019-07-29
Q1 2019 $105M -$3.6M -3.31% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $106M -$1.9M -1.76% Dec 31, 2018 10-K 2021-02-23
Q3 2018 $106M -$800K -0.75% Sep 30, 2018 10-Q 2018-10-30
Q2 2018 $107M +$800K +0.76% Jun 30, 2018 10-Q 2018-07-31
Q1 2018 $109M +$5.3M +5.12% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $108M +$4.7M +4.56% Dec 31, 2017 10-K 2020-02-24
Q3 2017 $107M +$1.9M +1.81% Sep 30, 2017 10-Q 2017-10-31
Q2 2017 $106M +$900K +0.86% Jun 30, 2017 10-Q 2017-08-01
Q1 2017 $104M -$2.2M -2.08% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 $103M -$1.6M -1.53% Dec 31, 2016 10-K 2019-02-28
Q3 2016 $105M -$500K -0.47% Sep 30, 2016 10-Q 2016-10-31
Q2 2016 $105M -$400K -0.38% Jun 30, 2016 10-Q 2016-08-01
Q1 2016 $106M +$1.3M +1.25% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 $105M -$4M -3.68% Dec 31, 2015 10-K 2018-02-26
Q3 2015 $106M -$4.7M -4.26% Sep 30, 2015 10-Q 2015-11-02
Q2 2015 $105M -$8.7M -7.63% Jun 30, 2015 10-Q 2015-08-03
Q1 2015 $104M -$9.8M -8.58% Mar 31, 2015 10-Q 2015-05-06
Q4 2014 $109M -$5.6M -4.9% Dec 31, 2014 10-K 2017-02-28
Q3 2014 $110M -$3M -2.65% Sep 30, 2014 10-Q 2014-11-03
Q2 2014 $114M +$2.3M +2.06% Jun 30, 2014 10-Q 2014-08-01
Q1 2014 $114M +$3.2M +2.88% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 $114M +$1.7M +1.51% Dec 31, 2013 10-K 2016-02-26
Q3 2013 $113M +$1.9M +1.7% Sep 30, 2013 10-Q 2013-11-04
Q2 2013 $112M +$1.7M +1.55% Jun 30, 2013 10-Q 2013-08-05
Q1 2013 $111M -$1.7M -1.51% Mar 31, 2013 10-Q 2013-05-06
Q4 2012 $113M +$1M +0.9% Dec 31, 2012 10-K 2015-02-25
Q3 2012 $112M -$2.1M -1.85% Sep 30, 2012 10-Q 2012-11-05
Q2 2012 $110M -$6.1M -5.25% Jun 30, 2012 10-Q 2012-08-06
Q1 2012 $113M -$2.5M -2.17% Mar 31, 2012 10-Q 2012-05-04
Q4 2011 $112M -$1M -0.89% Dec 31, 2011 10-K 2014-02-27
Q3 2011 $114M -$200K -0.18% Sep 30, 2011 10-Q 2011-11-07
Q2 2011 $116M +$8.2M +7.6% Jun 30, 2011 10-Q/A 2011-08-08
Q1 2011 $115M Mar 31, 2011 10-Q 2011-05-05
Q4 2010 $113M Dec 31, 2010 10-K 2013-02-27
Q3 2010 $114M Sep 30, 2010 10-Q 2010-11-05
Q2 2010 $108M Jun 30, 2010 10-Q 2010-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.